Galmed Pharmaceuticals Ltd.
GLMD
$1.07
$0.1111.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.15% | 108.98% | 45.49% | 21.27% | 28.75% |
| Total Receivables | 28.87% | 220.74% | 75.98% | 26.67% | -44.68% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | 46.98% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.20% | 4.24% | 4.27% | 3.42% | 3.48% |
| Total Current Assets | 11.53% | 109.25% | 45.75% | 21.79% | 24.56% |
|
|
|||||
| Total Current Assets | 11.53% | 109.25% | 45.75% | 21.79% | 24.56% |
| Net Property, Plant & Equipment | -- | -- | -- | -100.00% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.03% | 71.98% | 28.67% | 11.25% | 18.78% |
|
|
|||||
| Total Accounts Payable | 24.74% | 13.80% | -5.42% | -30.39% | -8.96% |
| Total Accrued Expenses | -- | -- | -- | 3.49% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -31.91% | 199.72% | 30.63% | -- | 89.95% |
| Total Other Current Liabilities | -31.91% | 199.72% | 30.63% | -- | 89.95% |
| Total Current Liabilities | -1.67% | 55.79% | 2.38% | -20.98% | 20.23% |
|
|
|||||
| Total Current Liabilities | -1.67% | 55.79% | 2.38% | -20.98% | 20.23% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -1.67% | 55.79% | 2.38% | -20.98% | 20.23% |
|
|
|||||
| Common Stock & APIC | 4.33% | 8.40% | 5.50% | 4.79% | 4.32% |
| Retained Earnings | -4.41% | -4.46% | -3.78% | -3.90% | -3.31% |
| Treasury Stock & Other | 7.60% | 7.36% | 12.75% | 8.37% | 43.66% |
| Total Common Equity | 3.67% | 74.12% | 32.31% | 17.64% | 18.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.67% | 74.12% | 32.31% | 17.64% | 18.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.67% | 74.12% | 32.31% | 17.64% | 18.58% |
|
|
|||||